Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$693M |
| 2 |
Constellation Brands
STZ
|
+$368M |
| 3 |
Tesla
TSLA
|
+$332M |
| 4 |
NVIDIA
NVDA
|
+$300M |
| 5 |
Booking.com
BKNG
|
+$251M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charter Communications
CHTR
|
+$821M |
| 2 |
Netflix
NFLX
|
+$777M |
| 3 |
AbbVie
ABBV
|
+$583M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$477M |
| 5 |
FedEx
FDX
|
+$456M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.07% |
| 2 | Consumer Discretionary | 17.72% |
| 3 | Financials | 13.25% |
| 4 | Healthcare | 11.94% |
| 5 | Communication Services | 11.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LOGM
276
DELISTED
LogMein, Inc.
LOGM
| $45.5M | 0.04% |
440,675
-19,377
| -4% | -$2.17M |
|
277
Cheniere Energy
CQP
$31B
| $45.4M | 0.04% |
1,262,694
+50,160
| +4% | +$1.65M |
|
278
Madrigal Pharmaceuticals
MDGL
$12.4B
| $45.3M | 0.04% |
161,785
-66,873
| -29% | -$11.7M |
|
|
AET
279
DELISTED
Aetna Inc
AET
| $44.7M | 0.04% |
243,407
+4,903
| +2% | +$874K |
|
280
Terex
TEX
$7.84B
| $44.5M | 0.04% |
1,055,169
+463
| +0% | +$18.4K |
|
|
AQUA
281
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $44.3M | 0.04% |
2,159,610
+47,108
| +2% | +$961K |
|
282
Allison Transmission
ALSN
$10B
| $44.1M | 0.04% |
1,088,106
-1,290,701
| -54% | -$53.1M |
|
|
CXP
283
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $43.9M | 0.04% |
1,932,820
+1,014,257
| +110% | +$22M |
|
|
SEMG
284
DELISTED
SEMGROUP CORPORATION
SEMG
| $43.5M | 0.04% |
1,714,134
+5,811
| +0.3% | +$142K |
|
|
AGR
285
DELISTED
Avangrid, Inc.
AGR
| $43.3M | 0.04% |
817,523
| – | – |
|
286
Incyte
INCY
$26B
| $43.2M | 0.04% |
645,183
-299,237
| -32% | -$20.5M |
|
287
Texas Roadhouse
TXRH
$13.5B
| $43.1M | 0.04% |
658,556
+8,242
| +1% | +$517K |
|
288
IQVIA
IQV
$40B
| $42.5M | 0.04% |
425,707
-309,858
| -42% | -$31M |
|
|
NEWR
289
DELISTED
New Relic, Inc.
NEWR
| $42.1M | 0.04% |
418,392
-93,064
| -18% | -$8.27M |
|
290
NN Inc
NNBR
$261M
| $41.6M | 0.04% |
2,201,181
+19,728
| +0.9% | +$425K |
|
291
Shopify
SHOP
$169B
| $41.5M | 0.04% |
2,842,580
+1,217,910
| +75% | +$17.2M |
|
|
GWR
292
DELISTED
Genesee & Wyoming Inc.
GWR
| $41.2M | 0.04% |
507,126
-1,342
| -0.3% | -$102K |
|
293
Clorox
CLX
$12.1B
| $40.8M | 0.04% |
301,895
+59,862
| +25% | +$7.39M |
|
|
CLR
294
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $40.2M | 0.04% |
620,907
-77,857
| -11% | -$5.03M |
|
|
VIAB
295
DELISTED
Viacom Inc. Class B
VIAB
| $40.1M | 0.04% |
1,328,243
-12,499
| -0.9% | -$368K |
|
296
Cactus
WHD
$3.69B
| $39.7M | 0.04% |
1,175,314
-17,326
| -1% | -$536K |
|
297
Delta Air Lines
DAL
$58.8B
| $39.5M | 0.04% |
796,770
+139,248
| +21% | +$7.43M |
|
298
Neurocrine Biosciences
NBIX
$18.4B
| $39.3M | 0.04% |
400,412
+7,877
| +2% | +$705K |
|
|
AXE
299
DELISTED
Anixter International Inc
AXE
| $39.1M | 0.04% |
617,419
-144,431
| -19% | -$9.64M |
|
|
BOLD
300
DELISTED
Audentes Therapeutics, Inc
BOLD
| $39M | 0.04% |
1,020,556
+17,877
| +2% | +$662K |
|
Similar funds
Jennison Associates's Q2 2018 Portfolio in Review
As of Q2 2018, Jennison Associates held 740 positions worth $103B, up 2% from $101B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Jennison Associates withdrew a net $3.95B in Q2 2018, closing 87 positions and reducing 296 holdings. Its most notable exit was Great Plains Energy Incorporated, an estimated $152M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Jennison Associates opened a new position in AstraZeneca worth $677M.
- Jennison Associates's largest Q2 2018 buy was AstraZeneca: 9,637,084 shares worth $677M.
- Jennison Associates added most to Constellation Brands in Q2 2018, an estimated $368M increase.
- Jennison Associates's biggest Q2 2018 reduction was Charter Communications, cutting an estimated $821M.
- Jennison Associates fully exited Great Plains Energy Incorporated in Q2 2018, selling an estimated $152M.
- Jennison Associates's ten largest holdings make up 29% of its $103B portfolio in Q2 2018.
- Jennison Associates opened 89 new positions and closed 87 in Q2 2018.
- Jennison Associates's portfolio value rose 2% quarter-over-quarter to $103B.
Based on Jennison Associates's 13F filing for Q2 2018, filed 2 Aug 2018.